Asked by: Baroness Coussins (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what plans they have to provide funding for the Lingo Flamingo project to help dementia sufferers with their cognitive abilities, in England, as is currently the case in Scotland.
Answered by Baroness Blackwood of North Oxford
We have no plans to fund the Lingo Flamingo project for England.
NHS England allocates funding to clinical commissioning groups (CCGs) and NHS England Specialised Commissioning which commission services on behalf of their local populations. It is for CCGs and Specialised Commissioning to decide how best to use the funding allocated to them in line with local healthcare needs and priorities, working with other local commissioners and organisations and taking account of National Institute for Health and Care Excellence guidelines.
Asked by: Baroness Coussins (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government what action they plan to take to ensure that treatment for bladder cancer under the NHS is accessible equally by all patients irrespective of home address.
Answered by Lord Prior of Brampton
NHS England is not aware of any general variation in access to bladder cancer treatment.
Asked by: Baroness Coussins (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government what support they are giving to the campaign by Public Health England and various cancer charities to raise awareness of bladder cancer.
Answered by Lord Prior of Brampton
The “Blood in Pee” campaign focuses on early symptoms of bladder and kidney cancer. The campaign has run twice at a national level from 15 October to 20 November 2013 and 13 October to 23 November 2014, following successful local and regional pilots and will be re-running from 15 February to 31 March 2016. The campaign will use a wide range of media, including national television and radio advertising, to promote the key message “If you notice blood in your pee, even if it’s just the once, tell your doctor”.
Public Health England (PHE) works closely with the Department and NHS England to ensure that health care professionals are also targeted with campaign information to encourage earlier diagnoses and referrals. PHE also works closely with the devolved administrations to ensure consistency of messages on their own campaigns and initiatives.
The Department notifies key stakeholders including charities about forthcoming campaigns and has engaged with relevant charities to review the campaign leaflet and source case studies for the bladder and kidney campaign. A copy of the leaflet has been attached
Information for the general public will be available on NHS Choices. This is an online only resource.
Asked by: Baroness Coussins (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government what is their assessment of the BCG vaccine treatment of bladder cancer.
Answered by Lord Prior of Brampton
We have made no such assessment.
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing best practice guidance for the National Health Service.
NICE published a clinical guideline in February 2015 on the diagnosis and management of bladder cancer which outlines the circumstances in which the Bacille Calmette‑Guérin (BCG) vaccine should be used to treat bladder cancer. A copy of the clinical guideline is attached.
A bladder cancer quality standard was also published by NICE in December 2015 which refers to BCG treatment for bladder cancer. A copy of the quality standard is attached.